Glicociência

L-Talose is a type of sugar that is found in plants and animals. It is a stereoselective, synthetic carbohydrate with the chemical formula C12H24O11. L-Talose has an anhydrous dextrose equivalent (DE) of 180. L-Talose is synthesized from D-glucal and D-talonol by a recombinant protein. The immobilization process has been shown to be successful for the production of L-talose as it prevents the loss of product due to adsorption on the surface of the reactor. Molecular modeling was used to determine that L-talose binds to carbonyl groups more strongly than other types of molecules. Anhydrous dextrose was shown to be an effective acceptor for L-talose because it reacts with hydroxyl groups at room temperature and pressure conditions. The nmr spectra show that the hydroxyl group interacts with hydrogen bonding and coordinate covalent bonding

4-Methoxyphenyl 2-acetamido-4-O-(2,3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-3,6-di-O-benzyl-2,3′:6′,4′:5″,6′″:5″′:3″″:4″″′:5″″′:6′″′-[1]benzothiadiazole (MTBT) is a synthetic monosaccharide sugar that is modified to have a 1,2,3,4,5 and 6 benzothiadiazole group. MTBT is a complex carbohydrate that is synthesized through methylation of the sugar followed by a click modification. It has been used in the synthesis of oligosaccharides and polysaccharides.

3,5-Dimethyl-D-fructose is a glycosylation product of 3,5-dimethoxy-4-hydroxybenzoic acid and D-glucose. It can be synthesized by the reaction of 3,5-dimethoxy-4-hydroxybenzoic acid with D-glucose in the presence of sodium cyanoborohydride. This product has been used as a reactant in click chemistry and as a fluorinating agent for saccharides. 3,5-Dimethyl-D-fructose is a custom synthesis that can be ordered in high purity at CAS No. 52674-57-6.br>br>
3,5 - Dimethyl - D - fructose
is an oligosaccharide that is used as an intermediate in the synthesis of other sugars. This product has been shown to have antiinflammatory properties due to its inhibition of prostaglandin synthesis.br

Competitive inhibitor of glucosylceramidase (GlcCer), which catalyses the first step in glycosphingolipid (GSL) synthesis. This compound is a promising candidate for substrate reduction therapy in Sandhoff disease, where it decreases the rate of GSL biosynthesis and counterbalances the impaired rate of ganglioside catabolism.

2,3,4,6-Tetra-O-pivaloyl-D-mannopyranosyl fluoride is a carbohydrate that is synthesized by the modification of D-mannose with 4,6-dichlorohexanoic acid. It is a white powder with a melting point of 170°C. 2,3,4,6-Tetra-O-pivaloyl-D-mannopyranosyl fluoride can be used as a monosaccharide for glycosylation reactions or as an intermediate for custom synthesis. This product has been methylated and glycosylated before the final purification process. It has a high purity level and can be used in Click chemistry reactions.

D-ribono-1,5-lactone is a useful intermediate for the synthesis of bioactive compounds including antivirals.

PolyGlycopleX (PGX) is produced from a mixture containing proprietary proportions of three polysaccharides, konjac glucomannan, xanthan gum and sodium alginate.  Recent hydrodynamic, rheological and analytical studies have shown that the unexpectedly high viscosity of solutions of PGX is consistent with an interaction between a konjac glucomannan, xanthan gum complex and sodium alginate to form a new, ternary complex in solution. Human and animal feeding studies have shown that PGX can be used to control weight, lower the glycaemic index of foods and postprandial glycaemia.

2,3,4,6-Tetra-O-acetyl-D-galactopyranosyl azide is a fluorinated sugar that can be used as a synthetic intermediate for the glycosylation of polysaccharides. This compound has been shown to have high purity and does not react with other compounds in the reaction mixture.

Fuculose is a monosaccharide that is a constituent of fucose-containing glycoproteins. It is found in the blood and urine, as well as in various tissues, such as liver, lung, kidney, and spleen. The biological properties of L-fuculose are related to its ability to form hydrogen bonds with other molecules. Fuculose has been shown to be an effective activator for cutaneous lesions in mice models. The structural analysis of L-fuculose has revealed that it contains a reactive site for the synthesis of glycosaminoglycans and polysaccharides. Fuculose has also been shown to increase the proliferation of some cells, including corynebacterium glutamicum and human umbilical vein endothelial cells (HUVECs). This property may be due to its ability to activate growth factors or interfere with cell signaling pathways.

2,4-Dideoxy-2,4-difluoro-D-glucose is a fluorinated glucose analog that has been synthesized to be used as an imaging agent for positron emission tomography (PET) and single photon emission computed tomography (SPECT). It is labeled with fluorine-18 and can be metabolically incorporated into the cellular glycolytic pathway. 2,4-Dideoxy-2,4-difluoro-D-glucose emits positrons that are detected by PET or SPECT cameras. The incorporation of 2,4-dideoxy-2,4-difluoro--D--glucose into the glycolytic pathway allows it to be used as a marker for positron emission tomography.

The chemical structure of Astragalus polysaccharide is complex and consists of an α-D-(1,4)-Glc and (1,6)-α-D-Glcp backbone, and a branch point at O-6. The molecular weight is approximately 3.01 × 105 Da from Mongolian Astragalus using low concentration of ethanol for precipitation and gel chromatography for purification. Spectral analysis results of 1H NMR and 13C NMR showed that the polysaccharide backbone has a 1,3-linked β-D-Gal residue and the branched portion has β-Glc, 1,6-linked α-Gal; 1,5-linked β-Xyl; 1,4-linked β-Gal; β-D-Gal, 1,2-linked α-Rha; and 1,2,4-linked α-Rha residues.